Feasibility Assessment of a Patients Follow-up Visit Receiving Trastuzumab Subcutaneous by Advanced Practice Nurse

Inclusion Criteria:

* Patient care at the Cancer Institute Lucien Neuwirth
* Patient aged over 18 years
* Patient with breast cancer overexpressing HER2 adjuvant
* Patient having finished their chemotherapy treatment with IV followed the oncologist day hospital
* Patient under Trastzumab subcutaneously
* Patient affiliated or entitled to a social security scheme (mandatory requirement for all studies)

Exclusion Criteria:

* Refusal to participate, most patient protected under guardianship.
* Patient in inability to understand the course of the study
* Patient with documented history of cognitive or psychiatric disorders.
* Patients pregnant or lactating
* Patients under guardianship or curatorship